Skip to main content
Teva Pharmaceutical Industries Limited (TEVJF)
OTCMKTS · Delayed Price · Currency is USD
13.73
-1.02 (-6.92%)
At close: Apr 7, 2025

TEVJF Revenue

In the year 2024, Teva Pharmaceutical Industries had annual revenue of $16.54B with 4.40% growth. Teva Pharmaceutical Industries had revenue of $4.23B in the quarter ending December 31, 2024, a decrease of -5.12%.

Revenue
16.54B
Revenue Growth
+4.40%
P/S Ratio
1.03
Revenue / Employee
475.55K
Employees
35,686
Market Cap
17.06B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202416.54B698.00M4.40%
Dec 31, 202315.85B921.00M6.17%
Dec 31, 202214.93B-953.00M-6.00%
Dec 31, 202115.88B-781.00M-4.69%
Dec 31, 202016.66B-228.00M-1.35%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.76B
SS Innovations International 20.65M
Veradigm 588.02M
Elite Pharmaceuticals 70.00M
Northwest Biotherapeutics 1.38M
Glass House Brands 200.90M
BioStem Technologies 301.83M
American Oncology Network 1.76B
Revenue Rankings

Teva Pharmaceutical Industries News

More News